Your browser doesn't support javascript.
loading
Early B-cell development and B-cell maturation are impaired in patients with active hemophagocytic lymphohistiocytosis.
Shim, Jenny; Park, Sunita; Venkateswaran, Suresh; Kumar, Deepak; Prince, Chengyu; Parihar, Vaunita; Maples, Larkin; Waller, Edmund K; Kugathasan, Subra; Briones, Michael; Lee, Miyoung; Henry, Curtis J; Prahalad, Sampath; Chandrakasan, Shanmuganathan.
Afiliação
  • Shim J; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Park S; Department of Pathology, Children's Healthcare of Atlanta, Atlanta, GA.
  • Venkateswaran S; Division of Pediatric Gastroenterology, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Kumar D; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Prince C; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Parihar V; Cancer Tissue and Pathology Shared Resource Core, Emory University School of Medicine, Atlanta, GA.
  • Maples L; Department of Pathology, Children's Healthcare of Atlanta, Atlanta, GA.
  • Waller EK; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Kugathasan S; Division of Pediatric Gastroenterology, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Briones M; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Lee M; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Henry CJ; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Prahalad S; Division of Pediatric Rheumatology, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Chandrakasan S; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
Blood ; 142(23): 1972-1984, 2023 12 07.
Article em En | MEDLINE | ID: mdl-37624902
ABSTRACT
Hemophagocytic lymphohistiocytosis (HLH) is characterized by hyperinflammation and multiorgan dysfunction. Infections, including the reactivation of viruses, contribute to significant disease mortality in HLH. Although T-cell and natural killer cell-driven immune activation and dysregulation are well described, limited data exist on the status of B-cell compartment and humoral immune function in HLH. We noted marked suppression of early B-cell development in patients with active HLH. In vitro B-cell differentiation studies after exposure to HLH-defining cytokines, such as interferon gamma (IFN-γ) and tumor necrosis factor, recapitulated B-cell development arrest. Messenger RNA sequencing of human CD34+ cells exposed to IFN-γ demonstrated changes in genes and pathways affecting B-cell development and maturation. In addition, patients with active HLH exhibited a marked decrease in class-switched memory B (CSMB) cells and a decrease in bone marrow plasmablast/plasma cell compartments. The decrease in CSMB cells was associated with a decrease in circulating T follicular helper (cTfh) cells. Finally, lymph node and spleen evaluation in a patient with HLH revealed absent germinal center formation and hemophagocytosis with associated lymphopenia. Reassuringly, the frequency of CSMB and cTfh improved with the control of T-cell activation. Taken together, in patients with active HLH, these changes in B cells may affect the humoral immune response; however, further immune studies are needed to determine its clinical significance.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfo-Histiocitose Hemofagocítica Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfo-Histiocitose Hemofagocítica Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article